ACM
TXMD icon

ADAR1 Capital Management’s TherapeuticsMD TXMD Stock Holding History

ADAR1 Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Hold
209,210
– – 0.02% 215
2025
Q4 		$341K Hold
209,210
– – 0.03% 206
2025
Q3 		$225K Hold
209,210
– – 0.02% 175
2025
Q2 		$243K Sell
209,210
-60,950
-23% -$73.9K 0.04% 149
2025
Q1 		$250K Hold
270,160
– – 0.05% 138
2024
Q4 		$232K Hold
270,160
– – 0.05% 153
2024
Q3 		$448K Hold
270,160
– – 0.07% 122
2024
Q2 		$435K Sell
270,160
-2,000
-0.7% -$4.04K 0.08% 107
2024
Q1 		$623K Hold
272,160
– – 0.14% 75
2023
Q4 		$612K Buy
+272,160
New +$657K 0.22% 56

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ADAR1 Capital Management's TXMD Position: Q1 2026 in Review

ADAR1 Capital Management held its TherapeuticsMD (TXMD) position steady in Q1 2026 at 209,210 shares worth $423K. The position accounts for 0.02% of the portfolio, ranked #215.

ADAR1 Capital Management first reported a position in TXMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $623K in Q1 2024. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • ADAR1 Capital Management held 209,210 shares of TherapeuticsMD worth $423K as of Q1 2026.
  • ADAR1 Capital Management left its TherapeuticsMD share count unchanged in Q1 2026.
  • TherapeuticsMD made up 0.02% of ADAR1 Capital Management's portfolio in Q1 2026, its #215 holding.
  • ADAR1 Capital Management first reported a position in TherapeuticsMD in Q4 2023 and has held it in 10 quarters since.
  • ADAR1 Capital Management's TherapeuticsMD position peaked at $623K in Q1 2024.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.